↓ Skip to main content

PLOS

A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers

Overview of attention for article published in PLOS ONE, January 2013
Altmetric Badge

Mentioned by

twitter
1 X user
patent
3 patents
facebook
1 Facebook page

Readers on

mendeley
46 Mendeley
Title
A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers
Published in
PLOS ONE, January 2013
DOI 10.1371/journal.pone.0054644
Pubmed ID
Authors

Jeeyun Lee, Sung Kim, Phillip Kim, Xinjun Liu, Tani Lee, Kyoung-Mee Kim, In-Gu Do, Joon Oh Park, Hoon Park, Jiryeon Jang, Nicholas Hoe, Gulia Harvie, Anne Kuller, Anjali Jain, Gary Meyer, Glen Leesman, Young Suk Park, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Ho Yeong Lim, Sharat Singh, Won Ki Kang

Abstract

The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 45 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 28%
Student > Ph. D. Student 6 13%
Student > Postgraduate 5 11%
Student > Master 4 9%
Student > Bachelor 3 7%
Other 7 15%
Unknown 8 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 16 35%
Biochemistry, Genetics and Molecular Biology 9 20%
Medicine and Dentistry 7 15%
Psychology 2 4%
Immunology and Microbiology 1 2%
Other 3 7%
Unknown 8 17%